✦ LIBER ✦

Su1056 Effect of HCV Genotype-1 Subtype on Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Treatment-Naïve Patients: Pooled Data From Phase III Trials

✍ Scribed by Jacobson, Ira M.; Jensen, Donald M.; Dieterich, Douglas T.; Sarrazin, Christoph; Foster, Graham; Yoshida, Eric M.; Nelson, Mark; Ingiliz, Patrick; Soriano, Vicente; Cooper, Curtis; Stern, Jerry O.; Quinson, Anne-Marie; Kukolj, George; Scherer, Joseph; Drulak, Murray; Gallivan, John-Paul; Schobelock, Michael; Ferenci, Peter

Book ID: 122124330
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 397 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)63547-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1129 EFFECT OF HCV GENOTYPE-1 SUBTYPE O

P1129 EFFECT OF HCV GENOTYPE-1 SUBTYPE ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: POOLED DATA FROM PHASE III TRIALS

✍ Jacobson, I.M.; Jensen, D.M.; Dieterich, D.; Sarrazin, C.; Foster, G.R.; Yoshida 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Su1060 Faldaprevir Plus Pegylated Interf

Su1060 Faldaprevir Plus Pegylated Interferon/Ribavirin Did Not Increase Anaemia Compared With Pegylated Interferon/Ribavirin in HCV Genotype-1, Treatment-Naïve Patients: Pooled Analysis of Phase III Studies

✍ Asselah, Tarik; Jensen, Donald M.; Foster, Graham; Sulkowski, Mark; Ouzan, Denis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Su1058 Early Stopping Rules for Faldapre

Su1058 Early Stopping Rules for Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Treatment-Naïve Patients: Exploratory Study of Pooled Data From Phase III Trials

✍ Ferenci, Peter; Dieterich, Douglas T.; Zeuzem, Stefan; Mantry, Parvez S.; Sarraz 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 233 KB

P723 FALDAPREVIR PLUS PEGYLATED INTERFER

P723 FALDAPREVIR PLUS PEGYLATED INTERFERON/RIBAVIRIN DID NOT INCREASE ANAEMIA COMPARED WITH PEGYLATED INTERFERON/RIBAVIRIN IN HCV GENOTYPE-1, TREATMENT-NAIVE PATIENTS: POOLED ANALYSIS OF PHASE III STUDIES

✍ Asselah, T.; Jensen, D.M.; Foster, G.R.; Sulkowski, M.S.; Ouzan, D.; Morano, L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Su1053 Virological Response in Treatment

Su1053 Virological Response in Treatment-Naïve Patients With Chronic HCV Genotype-1 Infection Receiving Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin Is Unaffected by Ribavirin Dose Reduction

✍ Asselah, Tarik; Jensen, Donald M.; Foster, Graham; Sulkowski, Mark; Ouzan, Denis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 1018 KB

Su1055 Impact of Baseline Variables on R

Su1055 Impact of Baseline Variables on Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Patients With HIV/HCV Genotype-1 Coinfection in a Phase III Trial

✍ Tural, Cristina; Rockstroh, Jürgen K.; Nelson, Mark; Bhagani, Sanjay; Ingiliz, P 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 397 KB